Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:JJU NASDAQ:NRBO OTCMKTS:PWCO NYSE:SOS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJJUiPath Series B Bloomberg Aluminum Subindex Total Return ETN$45.88$45.88$43.37▼$59.10$5.51MN/A2,747 shsN/ANRBONeuroBo Pharmaceuticals$0.63-2.0%$0.65$2.08▼$4.41$5.46M-0.2639,605 shs16,755 shsPWCOPWRCOR$0.01$0.01$0.00▼$0.06$1.45M1.798,813 shsN/ASOSSOS$1.21-25.8%$4.69$1.02▼$15.51$3.79M2.11175,379 shs1.04 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJJUiPath Series B Bloomberg Aluminum Subindex Total Return ETN0.00%0.00%0.00%0.00%0.00%NRBONeuroBo Pharmaceuticals0.00%-2.43%+4.81%-2.46%-82.81%PWCOPWRCOR0.00%0.00%+70.00%-70.43%-82.61%SOSSOS0.00%-30.66%-51.41%-81.66%-88.61%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationJJUiPath Series B Bloomberg Aluminum Subindex Total Return ETNN/AN/AN/AN/AN/AN/AN/AN/ANRBONeuroBo PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/APWCOPWRCORN/AN/AN/AN/AN/AN/AN/AN/ASOSSOS0.0585 of 5 stars0.02.00.00.00.60.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceJJUiPath Series B Bloomberg Aluminum Subindex Total Return ETN 0.00N/AN/AN/ANRBONeuroBo Pharmaceuticals 0.00N/AN/AN/APWCOPWRCOR 0.00N/AN/AN/ASOSSOS 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookJJUiPath Series B Bloomberg Aluminum Subindex Total Return ETNN/AN/AN/AN/AN/AN/ANRBONeuroBo PharmaceuticalsN/AN/AN/AN/A$1.50 per shareN/APWCOPWRCOR$100K14.50N/AN/AN/A∞SOSSOS$231.42M0.02N/AN/A$139.30 per share0.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateJJUiPath Series B Bloomberg Aluminum Subindex Total Return ETNN/AN/A0.00∞N/AN/AN/AN/AN/ANRBONeuroBo Pharmaceuticals-$12.47MN/A0.00N/AN/AN/A-189.12%-122.31%11/5/2025 (Estimated)PWCOPWRCOR-$80KN/A0.00∞N/AN/AN/AN/AN/ASOSSOS-$13.60MN/A0.00∞N/AN/AN/AN/A9/25/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthJJUiPath Series B Bloomberg Aluminum Subindex Total Return ETNN/A0.00%N/AN/AN/ANRBONeuroBo PharmaceuticalsN/AN/AN/AN/AN/APWCOPWRCORN/AN/AN/AN/AN/ASOSSOSN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioJJUiPath Series B Bloomberg Aluminum Subindex Total Return ETNN/AN/AN/ANRBONeuroBo PharmaceuticalsN/A2.412.41PWCOPWRCORN/AN/AN/ASOSSOSN/A9.979.97Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipJJUiPath Series B Bloomberg Aluminum Subindex Total Return ETNN/ANRBONeuroBo Pharmaceuticals1.37%PWCOPWRCORN/ASOSSOS1.92%Insider OwnershipCompanyInsider OwnershipJJUiPath Series B Bloomberg Aluminum Subindex Total Return ETNN/ANRBONeuroBo Pharmaceuticals1.05%PWCOPWRCOR61.20%SOSSOS2.74%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableJJUiPath Series B Bloomberg Aluminum Subindex Total Return ETN2,020120,000N/ANot OptionableNRBONeuroBo Pharmaceuticals108.62 million8.53 millionNot OptionablePWCOPWRCORN/A213.20 million82.72 millionNot OptionableSOSSOS1703.13 million3.04 millionNo DataPWCO, NRBO, JJU, and SOS HeadlinesRecent News About These CompaniesSOS Limited Announces Termination of Deposit Agreement, Concurrent Changes to Share Capital and Direct Listing of Ordinary SharesAugust 28, 2025 | prnewswire.comContrasting SOS (NYSE:SOS) and Firefly Neuroscience (NASDAQ:AIFF)August 26, 2025 | americanbankingnews.comMassive SOS Stock Fraud Evidence + Potential Hindenburg Short ReportAugust 20, 2025 | msn.comSOS Limited Announces Pricing of $7.5 Million Registered Direct OfferingJuly 30, 2025 | prnewswire.comSOS Limited Navigates Growth Amid Regulatory ChallengesMay 26, 2025 | tipranks.comSOS Limited (SOS) Shares Climb 8.8% Following Recent Performance Boost | SOS Stock NewsMay 16, 2025 | gurufocus.comSOS Limited Reports 2024 Financial ResultsMay 15, 2025 | prnewswire.comSOS Limited Delays Annual Report FilingApril 30, 2025 | tipranks.comSOS Limited Completes $7.7 Million Private PlacementApril 11, 2025 | tipranks.comSOS Limited Announces $7.7 Million Private PlacementMarch 19, 2025 | tipranks.comSOS Limited files $500M mixed securities shelfMarch 16, 2025 | markets.businessinsider.comSOS Limited partners with Lepu Sodium Power for green energy solutionsFebruary 11, 2025 | msn.comSOS Limited Announces Entering into Strategic Partnership Framework Agreement with Lepu Sodium Power for SOS to Optimize its Electricity UseFebruary 11, 2025 | prnewswire.comSOS Limited (SOS)December 28, 2024 | finance.yahoo.comSOS Limited Announces Filing of the 2023 Annual Report on Form 20-FDecember 24, 2024 | gurufocus.comSOS Limited Announces Filing of the 2023 Annual Report on Form 20-FDecember 24, 2024 | globenewswire.comSolarMax Technology, Inc. and SOS Limited Partner to Develop Large-Scale Solar Power Facilities for Cryptocurrency OperationsDecember 10, 2024 | quiverquant.comQTrump Threatens Tariffs: Are Chinese Stocks Doomed?December 2, 2024 | zacks.comSOS Limited rises 27.8%November 29, 2024 | tipranks.comSOS Limited rises 36.8%November 29, 2024 | tipranks.comPWCO, NRBO, JJU, and SOS Company DescriptionsiPath Series B Bloomberg Aluminum Subindex Total Return ETN NYSEARCA:JJU$45.88 0.00 (0.00%) As of 06/14/2023The investment seeks to replicate, net of expenses, the Shiller Barclays CAPETM US Core Sector Index. The index seeks to provide a notional long exposure to the top four relatively undervalued U.S. equity sectors that also exhibit relatively strong price momentum. It incorporates the CAPE (Cyclically Adjusted Price Earnings) ratio to assess equity market valuations of nine sectors on a monthly basis and to identify the relatively undervalued sectors represented in the S&P 500.NeuroBo Pharmaceuticals NASDAQ:NRBO$0.63 -0.01 (-1.98%) As of 08/29/2025NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for metabolic dysfunction-associated steatohepatitis (MASH), and has completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus (T2DM); and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in preclinical development for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene. NeuroBo Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.PWRCOR OTCMKTS:PWCO$0.0068 0.00 (0.00%) As of 08/29/2025PwrCor, Inc. provides energy infrastructure and alternative energy solutions in the United States. The company manages infrastructure projects for commercial and institutional customers. Its projects include a combination of energy infrastructure components, including electrical power generation, steam production, or chilled water production projects, as well as the infrastructure to distribute these services. The company also commercializes engine technology that converts low-grade heat to mechanical energy for power generation. It serves domestic non-profit institutions and organizations; the waste-heat-to-energy and geothermal marketplace; and the independent power producer market. The company was formerly known as Receivable Acquisition & Management Corporation and changed its name to PwrCor, Inc. in March 2017. PwrCor, Inc. is headquartered in New York, New York.SOS NYSE:SOS$1.21 -0.42 (-25.77%) Closing price 08/29/2025 03:58 PM EasternExtended Trading$1.26 +0.05 (+4.55%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SOS Limited provides data mining and analysis services to corporate and individual members in the People's Republic of China. It provides marketing data, technology, and solutions for insurance companies; emergency rescue services; and insurance product and health care information portals. The company operates SOS cloud emergency rescue service software as a service platform that offers basic cloud products, such as medical rescue, auto rescue, financial rescue, and life rescue cards; cooperative cloud systems, including information rescue center, intelligent big data, and intelligent software and hardware; and information cloud systems, such as newsToday and E-commerce Today, 10086 hot-line center, information security services, and marketing-related data. It also focuses on cryptocurrency mining, blockchain-based insurance, and security management businesses. The company serves insurance companies, financial institutions, medical institutions, healthcare providers, and other service providers in the emergency rescue services industry. The company is based in Qingdao, the People's Republic of China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/25 - 08/29 Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Tencent Music Stock Outshines Spotify as China’s Music Giant With Shares Near Highs, Here's to Watch in Broadcom's Q3 Report Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
